BUSINESS Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets May 22, 2026
Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin tablets with US$ 10.487 billion market size Apr 7, 2026
Alembic Pharma secures USFDA final approval for Lamotrigine Orally Disintegrating Tablets Feb 26, 2026
Alembic Pharmaceuticals gets USFDA final approval for Carbidopa, Levodopa and Entacapone tablets Feb 6, 2026
Alembic Pharma Q3 Results: Revenue jumps 10.8% YoY to Rs 1,876 crore, net profit falls 3.9% Feb 5, 2026